1. Proliferation of MDA-MB-231 can be suppressed by dimeric-epigallocatechin gallate through competitive inhibition of amphiregulin-epidermal growth factor receptor signaling
    Yewei Huang et al, 2021, Anti-Cancer Drugs CrossRef
  2. YAP Overexpression in Breast Cancer Cells Promotes Angiogenesis through Activating YAP Signaling in Vascular Endothelial Cells
    Yu Yan et al, 2022, Analytical Cellular Pathology CrossRef
  3. Preoperative Serum Levels of PDGF-AB, PDGF-BB, TGF-α, EGF and ANG-2 in the Diagnosis of Endometrial Cancer
    Mateusz Kozłowski et al, 2023, Cancers CrossRef
  4. Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence
    Giovanna Azzarito et al, 2022, Cells CrossRef
  5. Staphylococcus aureus β-Toxin Exerts Anti-angiogenic Effects by Inhibiting Re-endothelialization and Neovessel Formation
    Phuong M. Tran et al, 2022, Frontiers in Microbiology CrossRef
  6. The role of Colchicine on actin polymerization dynamics: as a potent anti-angiogenic factor
    Samridhi Pathak et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
  7. Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer
    Katarzyna M. Terlikowska et al, 2020, BMC Cancer CrossRef
  8. Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
    Nehad M. Ayoub et al, 2022, Frontiers in Pharmacology CrossRef
  9. Peri-tumoural spatial distribution of lipid composition and tubule formation in breast cancer
    Kwok-Shing Chan et al, 2022, BMC Cancer CrossRef
  10. Serum Concentration of Selected Angiogenesis-Related Molecules Differs among Molecular Subtypes, Body Mass Index and Menopausal Status in Breast Cancer Patients
    Dimitrios Balalis et al, 2022, Journal of Clinical Medicine CrossRef
  11. Determination of Serum Angiopioetin-2 levels in Breast cancer patients at Damascus University Hospitals
    Majd Haidar et al, 2021, Research Journal of Pharmacy and Technology CrossRef
  12. Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
    Elżbieta Zarychta et al, 2023, International Journal of Molecular Sciences CrossRef
  13. Assessing angiogenesis factors as prognostic biomarkers in breast cancer patients and their association with clinicopathological factors
    Tannaz Abbasi-Dokht et al, 2024, Biomarkers CrossRef
  14. Implications of flavonoids as potential modulators of cancer neovascularity
    Alena Liskova et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
  15. Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
    Amelie Heesch et al, 2020, Cells CrossRef
  16. Novel angiogenic metal nanoparticles controlling intracellular gene activation in stem cells
    Gwang-Bum Im et al, 2021, Chemical Engineering Journal CrossRef

  17. In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin


    Charlaine A Aventurado et al, 2020, Drug Design, Development and Therapy CrossRef
  18. VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
    Maria Margarete Karsten et al, 2020, Scientific Reports CrossRef
  19. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
    Min Yang et al, 2023, Cancer Cell International CrossRef
  20. Role of Cytoskeletal Protein, Actin in Various Diseases
    Samridhi Pathak et al, 2021, Dietary Phytochemicals CrossRef
  21. Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication
    Saskia D. van Asten et al, 2018, Journal of Virology CrossRef